Skip to main content
Download PDF

Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan

Arthritis Research & Therapy volume 21, Article number: 99 (2019) Cite this article

The Original Article was published on 20 March 2019

Correction to: Arthritis Res Ther

https://doi.org/10.1186/s13075-019-1856-4

Following publication of the original article [1], the authors reported an error in Table 2. The data for ‘HAQ-DI response (MCID ≥ 0.3), n (%) / At week 52’ for the ‘Sarilumab 150 mg q2w + MTX’ and ‘Sarilumab 200 mg q2w + MTX’ groups should be 41 (50.6) and 37 (46.3), respectively (last row, last two entries of the table).

The corrected table is given below.

Table 2 Efficacy results (mITT population)
Full size table

Reference

  1. Tanaka, et al. Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan. Arthritis Res Ther. 2019;21:79. https://doi.org/10.1186/s13075-019-1856-4.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahata-nishi-ku, Kitakyushu, 807-8555, Japan

    Yoshiya Tanaka

  2. Sanofi K.K, Opera City Tower 3-20-2 Nishi-Shinjuku, Shinjuku-ku, Tokyo, 163-1488, Japan

    Kazuteru Wada & Yoshinori Takahashi

  3. Sanofi, 55 Corporate Drive, Bridgewater, NJ, 08807, USA

    Owen Hagino

  4. Sanofi-Genzyme, 500 Kendall St, Cambridge, MA, 02142, USA

    Hubert van Hoogstraten

  5. Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA

    Neil M. H. Graham

  6. Division of Rheumatology, Department of Internal Medicine, School of Medicine, Toho University, 2-22-36 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan

    Hideto Kameda

Authors
  1. Yoshiya Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazuteru Wada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshinori Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Owen Hagino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hubert van Hoogstraten
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Neil M. H. Graham
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hideto Kameda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshiya Tanaka.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tanaka, Y., Wada, K., Takahashi, Y. et al. Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan. Arthritis Res Ther 21, 99 (2019). https://doi.org/10.1186/s13075-019-1887-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13075-019-1887-x

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us